Kidney Cancer Research
Boston Medical Center has a wide variety of clinical trials mainly funded by the National Cancer Institute (NCI). NCI is coming up with new and innovative clinical trials for kidney cancers that are, or will be, available at Boston Medical Center.
CIRB #H-35254/SWOG #S1500 (PAPMET): A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib, Crizotinib, Savolitinib, and Sunitinib) in Metastatic Papillary Renal Carcinoma
HIRB #2016-19/Janssen RIVA STM4001: Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism